Ligand structural aspects of hERG channel blockade

Area of Science:

• Pharmacology
• Computational Chemistry
• Drug Safety

Background:

• Cardiovascular toxicity and sudden death are significant safety concerns linked to non-antiarrhythmic drugs.
• Undesirable blockade of the hERG potassium channel by various pharmaceuticals has led to market withdrawals.
• Understanding the interaction between diverse drug structures and the hERG channel is critical.

Purpose of the Study:

• To define the molecular features responsible for hERG channel inhibitory activity.
• To develop computational and statistical models for predicting hERG blockade.
• To facilitate the identification of potential hERG blockers in drug discovery pipelines.

Main Methods:

• Utilizing computational modeling to analyze structure-activity relationships (SAR) of drug-hERG interactions.
• Employing statistical modeling to identify key molecular features associated with hERG inhibition.
• Applying virtual screening approaches to filter large compound libraries for potential hERG blockers.

Main Results:

• Development of predictive models capable of identifying compounds likely to block the hERG channel.
• Identification of specific structural motifs correlated with hERG inhibitory activity.
• Demonstration of the utility of computational models in assessing drug safety profiles.

Conclusions:

• Computational and statistical modeling are essential tools for predicting and mitigating hERG-related cardiovascular risks.
• Understanding SAR is key to designing safer drugs and preventing adverse events.
• Model-driven hypothesis generation supports organization-wide adoption for enhanced drug safety assessment.